{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:52:41Z","timestamp":1769032361022,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","award":["CUP B83C22003930001\\u2013ECS_00000017"],"award-info":[{"award-number":["CUP B83C22003930001\\u2013ECS_00000017"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Airc Italian Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["30051"],"award-info":[{"award-number":["30051"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 23091"],"award-info":[{"award-number":["IG 23091"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bioorg.2025.109452","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:47:13Z","timestamp":1767210433000},"page":"109452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Natural products as payloads for antibody-drug conjugates: Cyclopamine linked to cetuximab for hedgehog pathway inhibition"],"prefix":"10.1016","volume":"169","author":[{"given":"Giovanni","family":"Ricciardella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ievoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Petricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetra","family":"Zambardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Stecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Montalbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Crivaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109452_bb0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0031-9422(00)86328-1","article-title":"Teratogenic compounds of Veratrum californicum. IV. First isolation of veratramine and alkaloid Q and a reliable method for isolation of cyclopamine","volume":"7","author":"Keeler","year":"1968","journal-title":"Phytochemistry (Elsevier)"},{"key":"10.1016\/j.bioorg.2025.109452_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/tera.1420010103","article-title":"Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources","volume":"1","author":"Keeler","year":"1968","journal-title":"Teratology"},{"key":"10.1016\/j.bioorg.2025.109452_bb0015","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1021\/jf0308206","article-title":"Biomedical applications of poisonous plant research","volume":"52","author":"James","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2025.109452_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.109952","article-title":"Beyond cyclopamine: targeting hedgehog signaling for cancer intervention","volume":"754","author":"Thazhackavayal Baby","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.109452_bb0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fgene.2019.00556","article-title":"Non-canonical hedgehog Signaling pathway in Cancer: activation of GLI transcription factors beyond smoothened","volume":"10","author":"Pietrobono","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.bioorg.2025.109452_bb0030","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1101\/gad.1025302","article-title":"Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened","volume":"16","author":"Chen","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2025.109452_bb0035","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1073\/pnas.182542899","article-title":"Small molecule modulation of smoothened activity","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Nat. Acad. Sci. U S A"},{"key":"10.1016\/j.bioorg.2025.109452_bb0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/tera.1420030209","article-title":"Teratogenic compounds in Veratrum californicum (Durand) IX. Structure-activity relation","volume":"3","author":"Keeler","year":"1970","journal-title":"Teratology"},{"key":"10.1016\/j.bioorg.2025.109452_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/tera.1420030210","article-title":"Teratogenic compounds in Veratrum californicum (Durand) X. Cyclopia in rap pits produced by cyclopamine","volume":"3","author":"Keeler","year":"1970","journal-title":"Teratology"},{"key":"10.1016\/j.bioorg.2025.109452_bb0050","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1021\/jm8008508","article-title":"Semisynthetic Cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists","volume":"51","author":"Tremblay","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109452_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910725","article-title":"Patidegib in dermatology: a current review","volume":"22","author":"Cosio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109452_bb0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/17512433.2023.2285849","article-title":"Pharmacokinetics and pharmacodynamics of hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma","volume":"16","author":"Lear","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109452_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jcph.2348","article-title":"Physiologically based pharmacokinetic Modeling of the drug-drug interaction between CYP3A4 substrate Glasdegib and moderate CYP3A4 inducers in lieu of a clinical study","volume":"64","author":"Callegari","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109452_bb0070","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1039\/D3MD00674C","article-title":"The medicinal chemistry evolution of antibody\u2013drug conjugates","volume":"15","author":"Hobson","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109452_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-024-01963-7","article-title":"A review of the clinical efficacy of FDA-approved antibody\u2013drug conjugates in human cancers","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.109452_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116233","article-title":"Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates","volume":"268","author":"Lu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109452_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13045-022-01397-y","article-title":"Payload diversification: a key step in the development of antibody\u2013drug conjugates","volume":"16","author":"Conilh","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2025.109452_bb0090","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1039\/C7SC05266A","article-title":"Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation","volume":"9","author":"Cini","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.109452_bb0095","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.18632\/oncotarget.3240","article-title":"Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor","volume":"6","author":"Vesci","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.109452_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01534","article-title":"ErbB2 targeted epigenetic modulation: anti-tumor efficacy of the ADC trastuzumab-HDACi ST8176AA1","volume":"9","author":"Milazzo","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.109452_bb0105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1039\/D0CC06131J","article-title":"Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibition","volume":"57","author":"Cianferotti","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.109452_bb0110","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1002\/anie.200902520","article-title":"Synthesis of Cyclopamine using a biomimetic and diastereoselective approach","volume":"48","author":"Giannis","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.109452_bb0115","doi-asserted-by":"crossref","first-page":"21760","DOI":"10.1021\/jacs.3c09085","article-title":"Convergent Total synthesis of (\u2212)-Cyclopamine","volume":"145","author":"Sofiadis","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109452_bb0120","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.bmc.2016.06.017","article-title":"Cyclopamine bioactivity by extraction method from Veratrum californicum","volume":"24","author":"Turner","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109452_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.plaphy.2024.109087","article-title":"Integration of induction, system optimization and genetic transformation in Veratrum californicum var. vitro cultures to enhance the production of cyclopamine and veratramine","volume":"216","author":"Zuo","year":"2024","journal-title":"Plant Physiol. Biochem."},{"key":"10.1016\/j.bioorg.2025.109452_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymben.2024.07.011","article-title":"Verazine biosynthesis from simple sugars in engineered Saccharomyces cerevisiae","volume":"85","author":"Winegar","year":"2024","journal-title":"Metab. Eng."},{"key":"10.1016\/j.bioorg.2025.109452_bb0135","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/s41467-024-49748-2","article-title":"Divergent and gram-scale syntheses of (\u2212)-veratramine and (\u2212)-cyclopamine","volume":"15","author":"Hou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109452_bb0140","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1039\/D2CC03052G","article-title":"A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery","volume":"58","author":"Migliorini","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.109452_bb0145","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1021\/acs.jcim.5c00037","article-title":"Machine learning for predicting the drug-to-antibody ratio (DAR) in the synthesis of antibody\u2013drug conjugates (ADCs)","volume":"65","author":"Angiolini","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.109452_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115794","article-title":"Melanoma management: exploring staging, prognosis, and treatment innovations","volume":"25","author":"Shalata","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109452_bb0155","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/s41388-021-01783-9","article-title":"Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma","volume":"40","author":"Pietrobono","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.109452_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1181014","article-title":"Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus","volume":"14","author":"Taha","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.109452_bb0165","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jpba.2010.02.017","article-title":"Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified","volume":"52","author":"Wilson","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2025.109452_bb0170","series-title":"Purification of Organic Chemicals, Purification of Laboratory Chemicals","first-page":"103","author":"Armarego","year":"2013"},{"key":"10.1016\/j.bioorg.2025.109452_bb0175","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/marc.201200227","article-title":"Multifunctional polypeptide-PEO nanoreactors via the hydrophobic switch","volume":"33","author":"Wu","year":"2012","journal-title":"Macromol. Rapid Commun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:55:05Z","timestamp":1768978505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682501332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"alternative-id":["S004520682501332X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109452","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products as payloads for antibody-drug conjugates: Cyclopamine linked to cetuximab for hedgehog pathway inhibition","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109452"}}